Abstract
Germline mutations in succinate dehydrogenase subunits B, C and D (SDHB, SDHC and SDHD), genes encoding subunits of mitochondrial complex II, cause hereditary paragangliomas and phaeochromocytomas. In SDHB (1p36)- and SDHC (1q21)-linked families, disease inheritance is autosomal dominant. In SDHD (11q23)-linked families, the disease phenotype is expressed only upon paternal transmission of the mutation, consistent with maternal imprinting. However, SDHD shows biallelic expression in brain, kidney and lymphoid tissues (Baysal et al., 2000). Moreover, consistent loss of the wild-type (wt) maternal allele in SDHD-linked tumours suggests expression of the maternal SDHD allele in normal paraganglia. Here we demonstrate exclusive loss of the entire maternal chromosome 11 in SDHD-linked paragangliomas and phaeochromocytomas, suggesting that combined loss of the wt SDHD allele and maternal 11p region is essential for tumorigenesis. We hypothesize that this is driven by selective loss of one or more imprinted genes in the 11p15 region. In paternally, but not in maternally derived SDHD mutation carriers, this can be achieved by a single event, that is, non-disjunctional loss of the maternal chromosome 11. Thus, the exclusive paternal transmission of the disease can be explained by a somatic genetic mechanism targeting both the SDHD gene on 11q23 and a paternally imprinted gene on 11p15.5, rather than imprinting of SDHD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abeln EC, Corver WE, Kuipers-Dijkshoorn NJ, Fleuren GJ and Cornelisse CJ . (1994). Br.J.Cancer, 70, 255–262.
Astrom K, Cohen JE, Willett-Brozick JE, Aston CE and Baysal BE . (2003). Hum.Genet., 113, 228–237.
Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye ES, Eng C and Maher ER . (2001). Am.J.Hum.Genet., 69, 49–54.
Balmain A, Gray J and Ponder B . (2003). Nat.Genet., 33 (Suppl), 238–244.
Baysal BE, Farr JE, Rubinstein WS, Galus RA, Johnson KA, Aston CE, Myers EN, Johnson JT, Carrau R, Kirkpatrick SJ, Myssiorek D, Singh D, Saha S, Gollin SM, Evans GA, James MR and Richard III CW . (1997). Am.J.Hum.Genet., 60, 121–132.
Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der MA, Taschner PE, Rubinstein WS, Myers EN, Richard III CW, Cornelisse CJ, Devilee P and Devlin B . (2000). Science, 287, 848–851.
Beerman H, Kluin PM, Hermans J, van de Velde CJ and Cornelisse CJ . (1990). Int.J.Cancer, 45, 34–39.
Biggs PJ, Vogel H, Sage M, Martin LA, Donehower LA and Bradley A . (2003). Oncogene, 22, 3288–3296.
Burns JL and Hassan AB . (2001). Development, 128, 3819–3830.
Cooke HJ and Hindley J . (1979). Nucleic Acids Res., 6, 3177–3197.
Dannenberg H, de Krijger RR, Zhao J, Speel EJ, Saremaslani P, Dinjens WN, Mooi WJ, Roth J, Heitz PU and Komminoth P . (2001). Am.J.Pathol., 158, 1937–1942.
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME . (1997). Cell, 91, 231–241.
Devilee P, Cleton-Jansen AM and Cornelisse CJ . (2001). Trends Genet., 17, 569–573.
Devilee P, van Schothorst EM, Bardoel AF, Bonsing B, Kuipers-Dijkshoorn N, James MR, Fleuren G, van der Mey AG and Cornelisse CJ . (1994). Genes Chromosomes Cancer, 11, 71–78.
Douwes Dekker PB, Kuipers-Dijkshoorn N, Hogendoorn PC, van der Mey AG and Cornelisse CJ . (2003). Hum.Pathol., 34, 690–698.
Edstrom E, Mahlamaki E, Nord B, Kjellman M, Karhu R, Hoog A, Goncharov N, Teh BT, Backdahl M and Larsson C . (2000). Am.J.Pathol., 156, 651–659.
Eng C, Kiuru M, Fernandez MJ and Aaltonen LA . (2003). Nat.Rev.Cancer, 3, 193–202.
Fournet JC, Mayaud C, de Lonlay P, Gross-Morand MS, Verkarre V, Castanet M, Devillers M, Rahier J, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM and Junien C . (2001). Am.J.Pathol., 158, 2177–2184.
Gicquel C, Raffin-Sanson ML, Gaston V, Bertagna X, Plouin PF, Schlumberger M, Louvel A, Luton JP and Le Bouc Y . (1997). J.Clin.Endocrinol.Metab., 82, 2559–2565.
Haralambieva E, Kleiverda K, Mason DY, Schuuring E and Kluin PM . (2002). J.Pathol., 198, 163–170.
Jordanova ES, Riemersma SA, Philippo K, Giphart-Gassler M, Schuuring E and Kluin PM . (2002). Genes Chromosomes Cancer, 35, 38–48.
Li YM, Franklin G, Cui HM, Svensson K, He XB, Adam G, Ohlsson R and Pfeifer S . (1998). J.Biol.Chem., 273, 28247–28252.
Lui WO, Chen J, Glasker S, Bender BU, Madura C, Khoo SK, Kort E, Larsson C, Neumann HP and Teh BT . (2002). Oncogene, 21, 1117–1122.
Mariman EC, van Beersum SE, Cremers CW, van Baars FM and Ropers HH . (1993). Hum.Genet., 91, 357–361.
Niemann S and Muller U . (2000). Nat.Genet., 26, 268–270.
Runge S, Nielsen FC, Nielsen J, Lykke-Andersen J, Wewer UM and Christiansen J . (2000). J.Biol.Chem., 275, 29562–29569.
Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, Colinayo V, Ruff TG, Milligan SB, Lamb JR, Cavet G, Linsley PS, Mao M, Stoughton RB and Friend SH . (2003). Nature, 422, 297–302.
Stewart CE and Rotwein P . (1996). Physiol. Rev., 76, 1005–1026.
Tycko B . (2000). J.Clin.Invest., 105, 401–407.
van der Mey AG, Cornelisse CJ, Hermans J, Terpstra JL, Schmidt PH and Fleuren GJ . (1991). Br.J.Cancer, 63, 298–302.
van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH and van de Kamp JJ . (1989). Lancet, 2, 1291–1294.
van Schothorst EM, Beekman M, Torremans P, Kuipers-Dijkshoorn NJ, Wessels HW, Bardoel AF, van der Mey AG, van der Vijver MJ, van Ommen GJ, Devilee P and Cornelisse CJ . (1998a). Hum.Pathol., 29, 1045–1049.
van Schothorst EM, Jansen JC, Grooters E, Prins DE, Wiersinga JJ, van der Mey AG, van Ommen GJ, Devilee P and Cornelisse CJ . (1998b). Am.J.Hum.Genet., 63, 468–473.
Waye JS, Creeper LA and Willard HF . (1987). Chromosoma, 95, 182–188.
Waziri M, Patil SR, Hanson JW and Bartley JA . (1983). J.Pediatr., 102, 873–876.
Weksberg R and Squire JA . (1996). Med.Pediatr.Oncol., 27, 462–469.
Acknowledgements
We thank CJ Haven for help with the FISH experiments and NJ Kuipers-Dijkshoorn for technical assistance. We acknowledge T van Wezel and M Lombaerts for helpful comments on the manuscript. This research was supported by a grant from the JANIVO foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hensen, E., Jordanova, E., van Minderhout, I. et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 23, 4076–4083 (2004). https://doi.org/10.1038/sj.onc.1207591
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207591
Keywords
This article is cited by
-
Wilms tumour resulting from paternal transmission of a TRIM28 pathogenic variant—A first report
European Journal of Human Genetics (2024)
-
The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes
Endocrine Pathology (2019)
-
Clinical progression and metachronous paragangliomas in a large cohort of SDHD germline variant carriers
European Journal of Human Genetics (2018)
-
A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes
Journal of Genetic Counseling (2017)
-
Syndromic gastrointestinal stromal tumors
Hereditary Cancer in Clinical Practice (2016)